Supplemental data

3 Months Ended

Mar. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

The following information is presented as supplemental data as required by the indentures governing the Company’s senior notes.

Condensed Consolidating Statements of Income



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
For the three months ended March 31, 2019	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Patient service operating revenues	$	2,635,152		$	—		$	—	$	2,635,152
Provision for uncollectible accounts	(5,463		)	—			—		(5,463		)
Net patient service operating revenues	2,629,689			—			—		2,629,689
Other revenues	113,423			—			—		113,423
Total net operating revenues	2,743,112			—			—		2,743,112
Operating expenses	2,402,605			—			—		2,402,605
Operating income	340,507			—			—		340,507
Debt expense	(131,519		)	—			—		(131,519		)
Other income	6,940			—			—		6,940
Income tax expense	56,746			—			—		56,746
Net income from continuing operations	159,182			—			—		159,182
Net income from discontinued operations, net of tax	30,305			9,237			463		20,605
Net income	189,487			9,237			463		179,787
Less: Net income attributable to noncontrolling interests	(40,198		)	(1,255		)	—		(38,943		)
Net income attributable to DaVita Inc.	$	149,289		$	7,982		$	463	$	140,844


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Comprehensive Income



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
For the three months ended March 31, 2019	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Net income	$	189,487		$	9,237		$	463	$	179,787
Other comprehensive loss	(12,627		)	—			—		(12,627		)
Total comprehensive income	176,860			9,237			463		167,160
Less: Comprehensive income attributable to the noncontrolling interests	(40,198		)	(1,255		)	—		(38,943		)
Comprehensive income attributable to DaVita Inc.	$	136,662		$	7,982		$	463	$	128,217


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Balance Sheets



	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
As of March 31, 2019	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Cash and cash equivalents	$	459,242	$	—	$	—	$	459,242
Restricted cash and equivalents	102,192		—		—		102,192
Accounts receivable, net	1,953,422		—		—		1,953,422
Other current assets	705,272		—		—		705,272
Current assets held for sale, net	6,004,948		629,422		3,288		5,372,238
Total current assets	9,225,076		629,422		3,288		8,592,366
Property and equipment, net	3,392,266		—		—		3,392,266
Operating lease right-of-use assets	2,736,536		—		—		2,736,536
Amortizable intangibles, net	118,324		—		—		118,324
Other long-term assets	334,374		—		—		334,374
Goodwill	6,799,368		—		—		6,799,368
Total assets	$	22,605,944	$	629,422	$	3,288	$	21,973,234
Current liabilities	$	6,477,567	$	—	$	—	$	6,477,567
Current liabilities held for sale	1,753,310		412,368		—		1,340,942
Payables to parent	—		72,539		3,288		(75,827		)
Long-term operating leases liabilities	2,625,776		—		—		2,625,776
Long-term debt and other long-term liabilities	6,519,574		—		—		6,519,574
Noncontrolling interests subject to put provisions	1,143,044		—		—		1,143,044
Total DaVita Inc. shareholders’ equity	3,875,354		144,515		—		3,730,839
Noncontrolling interests not subject to put provisions	211,319		—		—		211,319
Shareholders’ equity	4,086,673		144,515		—		3,942,158
Total liabilities and shareholder’s equity	$	22,605,944	$	629,422	$	3,288	$	21,973,234


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Cash Flows



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For the three months ended March 31, 2019	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
Cash flows from operating activities:
Net income	$	189,487		$	9,237		$	463		$	179,787
Changes in operating and intercompany assets and liabilities and non-cash items included in net income	(48,183		)	9,696			(463		)	(57,416		)
Net cash provided by operating activities	141,304			18,933			—			122,371
Cash flows from investing activities:
Additions of property and equipment	(198,878		)	(229		)	—			(198,649		)
Acquisitions	(11,274		)	—			—			(11,274		)
Proceeds from asset and business sales	13,903			—			—			13,903
Investments and other items	(4,109		)	(1,355		)	—			(2,754		)
Net cash used in investing activities	(200,358		)	(1,584		)	—			(198,774		)
Cash flows from financing activities:
Long-term debt	357,197			—			—			357,197
Intercompany	—			28,965			—			(28,965		)
Other items	(32,246		)	—			—			(32,246		)
Net cash (used in) provided by financing activities	324,951			28,965			—			295,986
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(921		)	—			—			(921		)
Net increase in cash, cash equivalents and restricted cash	264,976			46,314			—			218,662
Less: Net increase in cash, cash equivalents and restricted cash from discontinued operations	118,962			46,314			—			72,648
Net increase in cash, cash equivalents and restricted cash from continuing operations	146,014			—			—			146,014
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year	415,420			—			—			415,420
Cash, cash equivalents and restricted cash of continuing operations at end of the period	$	561,434		$	—		$	—		$	561,434

(1)

After elimination of the unrestricted subsidiaries and the physician groups.